Effect of phyllanthus niruri on metabolic parameters of patients with kidney stone: a perspective for disease prevention
- PMID: 29617079
- PMCID: PMC6092661
- DOI: 10.1590/S1677-5538.IBJU.2017.0521
Effect of phyllanthus niruri on metabolic parameters of patients with kidney stone: a perspective for disease prevention
Abstract
Phyllanthus niruri (P.niruri) or stone breaker is a plant commonly used to reduce stone risk, however, clinical studies on this issue are lacking.
Objective: To prospectively evaluate the effect of P. niruri on the urinary metabolic parameters of patients with urinary lithiasis.
Materials and methods: We studied 56 patients with kidney stones <10mm. Clinical, metabolic, and ultrasonography assessment was conducted before (baseline) the use of P. niruri infusion for 12-weeks (P. niruri) and after a 12-week (wash out) Statistical analysis included ANOVA for repeated measures and Tukey's/McNemar´s test for categorical variables. Significance was set at 5%.
Results: Mean age was 44±9.2 and BMI was 27.2±4.4kg/m2. Thirty-six patients (64%) were women. There were no significant changes in all periods for anthropometric and several serum measurements, including total blood count, creatinine, uric acid, sodium, potassium, calcium, urine volume and pH; a significant increase in urinary potassium from 50.5±20.4 to 56.2±21.8 mg/24-hour (p=0.017); magnesium/creatinine ratio 58±22.5 to 69.1±28.6mg/ gCr24-hour (p=0.013) and potassium/creatinine ratio 39.3±15.1 to 51.3±34.7mg/gCr24- hour (p=0.008) from baseline to wash out. The kidney stones decreased from 3.2±2 to 2.0±2per patient (p<0.001). In hyperoxaluria patients, urinary oxalate reduced from 59.0±11.7 to 28.8±16.0mg/24-hour (p=0.0002), and in hyperuricosuria there was a decrease in urinary uric acid from 0.77±0.22 to 0.54±0.07mg/24-hour (p=0.0057).
Conclusions: P.niruri intake is safe and does not cause significant adverse effects on serum metabolic parameters. It increases urinary excretion of magnesium and potassium caused a significant decrease in urinary oxalate and uric acid in patients with hyperoxaluria and hyperuricosuria. The consumption of P.niruri contributed to the elimination of urinary calculi.
Keywords: Disease; Kidney Calculi; Urolithiasis.
Copyright® by the International Brazilian Journal of Urology.
Conflict of interest statement
Conflict of interest: None declared.
Similar articles
-
Phyllanthus niruri normalizes elevated urinary calcium levels in calcium stone forming (CSF) patients.Urol Res. 2004 Oct;32(5):362-6. doi: 10.1007/s00240-004-0432-8. Epub 2004 Jun 19. Urol Res. 2004. PMID: 15221244 Clinical Trial.
-
The effect of Phyllanthus niruri on urinary inhibitors of calcium oxalate crystallization and other factors associated with renal stone formation.BJU Int. 2002 Jun;89(9):829-34. doi: 10.1046/j.1464-410x.2002.02794.x. BJU Int. 2002. PMID: 12010223
-
Body size and 24-hour urine composition.Am J Kidney Dis. 2006 Dec;48(6):905-15. doi: 10.1053/j.ajkd.2006.09.004. Am J Kidney Dis. 2006. PMID: 17162145
-
Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.Arch Ital Urol Androl. 2015 Jul 7;87(2):105-20. doi: 10.4081/aiua.2015.2.105. Arch Ital Urol Androl. 2015. PMID: 26150027 Review.
-
Phytotherapy and Herbal Medicines for Kidney Stones.Curr Drug Targets. 2021;22(1):22-30. doi: 10.2174/1389450121666200929115555. Curr Drug Targets. 2021. PMID: 32990535 Review.
Cited by
-
Efficacy of Phyllanthus niruri on improving liver functions in patients with alcoholic hepatitis: A double-blind randomized controlled trial.Indian J Pharmacol. 2021 Nov-Dec;53(6):448-456. doi: 10.4103/ijp.IJP_540_20. Indian J Pharmacol. 2021. PMID: 34975132 Free PMC article. Clinical Trial.
-
Editorial Comment: Fluid Intake and Dietary Factors and the Risk of Incident Kidney Stones in UK Biobank: A Population-based Prospective Cohort Study.Int Braz J Urol. 2021 Jul-Aug;47(4):894-895. doi: 10.1590/S1677-5538.IBJU.2021.04.04. Int Braz J Urol. 2021. PMID: 33848085 Free PMC article. No abstract available.
-
Effect of Phaseolus Vulgaris on Urinary Biochemical Parameters among Patients with Kidney Stones in Saudi Arabia.Nutrients. 2020 Oct 30;12(11):3346. doi: 10.3390/nu12113346. Nutrients. 2020. PMID: 33143212 Free PMC article. Clinical Trial.
-
Evaluation of acute and sub-acute toxicity of selected traditional antiurolithiatic medicinal plant extracts in Wistar albino rats.Toxicol Rep. 2020 Oct 6;7:1356-1365. doi: 10.1016/j.toxrep.2020.10.001. eCollection 2020. Toxicol Rep. 2020. PMID: 33102139 Free PMC article.
-
Evaluation of the efficacy of Phyllanthus niruri standardized extract combined with magnesium and vitamin B6 for the treatment of patients with uncomplicated nephrolithiasis.Med Pharm Rep. 2019 Apr;92(2):153-157. doi: 10.15386/mpr-1246. Epub 2019 Apr 25. Med Pharm Rep. 2019. PMID: 31086843 Free PMC article.
References
-
- Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int. 2003;63:1817–1823. - PubMed
-
- Curhan GC, Willett WC, Knight EL, Stampfer MJ. Dietary factors and the risk of incident kidney stones in younger women: Nurses' Health Study II. Arch Intern Med. 2004;164:885–891. - PubMed
-
- Pearle MS, Calhoun EA, Curhan GC. Urologic Diseases of America Project. Urologic diseases in America project: urolithiasis. J Urol. 2005;173:848–857. - PubMed
-
- Ettinger B, Pak CY, Citron JT, Thomas C, Adams-Huet B, Vangessel A. Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol. 1997;158:2069–2073. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical